Bravada Gold Corporation
BGAVF
$0.0269
$0.003916.96%
| Weiss Ratings | BGAVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | BGAVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | BGAVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.28 | |||
| Price History | BGAVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 31.22% | |||
| 30-Day Total Return | 74.68% | |||
| 60-Day Total Return | 115.20% | |||
| 90-Day Total Return | 7.60% | |||
| Year to Date Total Return | 146.79% | |||
| 1-Year Total Return | -13.78% | |||
| 2-Year Total Return | -30.13% | |||
| 3-Year Total Return | -38.86% | |||
| 5-Year Total Return | -54.41% | |||
| 52-Week High % Change | -52.38% | |||
| 52-Week Low % Change | 134.69% | |||
| Price | BGAVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.05 | |||
| 52-Week Low Price | $0.01 | |||
| 52-Week Low Price (Date) | Dec 24, 2024 | |||
| 52-Week High Price (Date) | Apr 08, 2024 | |||
| Valuation | BGAVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.08M | |||
| Enterprise Value | 3.08M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -21.05% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -9.58 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.03 | |||
| Enterprise Value/EBITDA (TTM) | -14.13 | |||
| Enterprise Value/EBIT | -9.37 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | BGAVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 148.14M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BGAVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 604 806 0626 | |||
| Address | 1199 West Hastings Street Vancouver, BC V6E 3T5 | |||
| Website | www.bravadagold.com | |||
| Country | Canada | |||
| Year Founded | 2009 | |||
| Profitability | BGAVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | BGAVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -53.34% | |||
| Return on Equity | -- | |||
| Income Statement | BGAVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -218.20K | |||
| EBIT (TTM) | -328.90K | |||
| Net Income (TTM) | -430.40K | |||
| Net Income Avl. to Common (TTM) | -430.40K | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -46.64% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | -33.33% | |||
| Balance Sheet | BGAVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.70K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 20.40K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -357.40K | |||
| Current Ratio (Q) | 0.030 | |||
| Book Value Per Share (Q) | $0.00 | |||
| Total Assets (Q) | 400.30K | |||
| Total Current Liabilities (Q) | 685.00K | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 757.70K | |||
| Total Common Equity (Q) | -357.40K | |||
| Cash Flow | BGAVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -61.40K | |||
| Cash from Financing (TTM) | 361.20K | |||
| Net Change in Cash (TTM) | -47.70K | |||
| Levered Free Cash Flow (TTM) | -245.10K | |||
| Cash from Operations (TTM) | -347.10K | |||
